Sun Pharma Advanced Research Co. gets stock exchange nod for promoter reclassification
Sun Pharma Advanced Research Company Ltd. (SPARC) has received No-Objection Letters from both the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) for the reclassification of certain individuals from the 'Promoter Group' to the 'Public' category. This move is in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The individuals seeking reclassification include Krishna Vrundavandas Valia, Sudhir Vrundavandas Valia, and Raksha Sudhir Valia. SPARC had previously intimated the exchanges about this request on July 27, August 10, and August 13, 2026. The company is required to ensure subsequent compliance with the applicable provisions of the SEBI Listing Regulations.
Key Highlights
- Stock exchanges grant no-objection for promoter reclassification.
- Individuals Krishna, Sudhir, and Raksha Valia to move from Promoter Group to Public.
- Reclassification is in line with SEBI Regulation 31A.
- Company to ensure subsequent regulatory compliance.
Price Impact
More from SPARC